CELC
Price
$12.54
Change
+$0.53 (+4.41%)
Updated
Jun 27 closing price
Capitalization
473.71M
39 days until earnings call
DOSEF
Price
$0.54
Change
+$0.19 (+54.29%)
Updated
Jun 23 closing price
Capitalization
3.12M
Interact to see
Advertisement

CELC vs DOSEF

Header iconCELC vs DOSEF Comparison
Open Charts CELC vs DOSEFBanner chart's image
Celcuity
Price$12.54
Change+$0.53 (+4.41%)
Volume$555.12K
Capitalization473.71M
Doseology Sciences
Price$0.54
Change+$0.19 (+54.29%)
Volume$550
Capitalization3.12M
CELC vs DOSEF Comparison Chart in %
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. DOSEF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Buy and DOSEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CELC: $12.54 vs. DOSEF: $0.54)
Brand notoriety: CELC and DOSEF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 329% vs. DOSEF: 14%
Market capitalization -- CELC: $473.71M vs. DOSEF: $3.12M
CELC [@Biotechnology] is valued at $473.71M. DOSEF’s [@Biotechnology] market capitalization is $3.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileDOSEF’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • DOSEF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CELC and DOSEF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 3 TA indicator(s) are bullish while DOSEF’s TA Score has 2 bullish TA indicator(s).

  • CELC’s TA Score: 3 bullish, 4 bearish.
  • DOSEF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, both CELC and DOSEF are a bad buy in the short-term.

Price Growth

CELC (@Biotechnology) experienced а +8.10% price change this week, while DOSEF (@Biotechnology) price change was +54.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CELC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($474M) has a higher market cap than DOSEF($3.12M). DOSEF YTD gains are higher at: 283.772 vs. CELC (-4.202). DOSEF has higher annual earnings (EBITDA): -296.52K vs. CELC (-114.96M). CELC has more cash in the bank: 206M vs. DOSEF (820K). DOSEF has less debt than CELC: DOSEF (0) vs CELC (98.7M). DOSEF has higher revenues than CELC: DOSEF (46.7K) vs CELC (0).
CELCDOSEFCELC / DOSEF
Capitalization474M3.12M15,202%
EBITDA-114.96M-296.52K38,772%
Gain YTD-4.202283.772-1%
P/E RatioN/AN/A-
Revenue046.7K-
Total Cash206M820K25,122%
Total Debt98.7M0-
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCDOSEF
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
55%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
53%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DOSEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIQPX11.800.12
+1.03%
Morgan Stanley Inst International Eq R6
IGSIX12.370.09
+0.73%
Impax Global Social Leaders Inst
TFFYX78.680.54
+0.69%
Touchstone Focused Y
KAUIX6.380.02
+0.31%
Federated Hermes Kaufmann IS
AISBX13.370.03
+0.22%
Aristotle Small Cap Eq C

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with ATXS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+4.41%
ATXS - CELC
47%
Loosely correlated
N/A
RXRX - CELC
47%
Loosely correlated
-6.85%
COGT - CELC
46%
Loosely correlated
-3.14%
CCCC - CELC
46%
Loosely correlated
-7.89%
TRDA - CELC
45%
Loosely correlated
-1.57%
More

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and PHGE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
PHGE - DOSEF
31%
Poorly correlated
-2.22%
BYSI - DOSEF
27%
Poorly correlated
-2.78%
ALDX - DOSEF
27%
Poorly correlated
-2.07%
NKTX - DOSEF
25%
Poorly correlated
-3.18%
CELC - DOSEF
22%
Poorly correlated
+4.41%
More